Computed tomography (CT) is an imaging procedure which uses special x-ray equipment to provide detailed images of internal organs, blood vessels, soft tissues and bones. It is also known as CAT scanning (computerized axial tomography). It provides cross-sectional images in multiple planes. It helps in diagnosis of cancer, circulatory conditions and disorders (coronary artery disease, blood clots and blood vessel aneurysms), kidney and bladder stone, spinal conditions, inflammatory diseases (ulcerative colitis and sinusitis), and injuries to head, skeletal system and internal organs.
The global computed tomography (CT) system market is growing at a significant rate due to increasing healthcare expenditure and growing geriatric population. The increasing prevalence of chronic diseases and improving healthcare infrastructure in developing countries are also driving the growth of the global computed tomography (CT) system market. However, the factors such as stringent regulatory requirements for the approval of CT devices and side effects of ionization radiation are inhibiting the growth of the global market.
Increasing incidence of cardiovascular diseases has also increased market penetration of interventional CT systems along with diagnostic equipment. The use of CT technology is also increasing in pre-clinical and animal studies for research. The micro CT and micro PET/SPECT are sizable markets that smaller companies can target and larger companies can acquire. Another area trending in the CT space is the development of innovative contrast agents. Developing new and effective, non-toxic or low toxic, disease specific molecular imaging tracer is where all imaging technology is headed.
Read Complete Report With TOC:
http://www.radiantinsights.com/research/global-ct-system-2021
The growth of CT system market in the field of diagnostic imaging has had a diminishing impact on the growth of the x-ray market which is gradually being phased out. The trend is more evident in developed markets, such as the United States and Europe. The growth of potential CT scanners in emerging markets is still high, where x-ray accounts for a large share of the medical imaging market. In these regions, the application of CT scans is still restricted to oncology only, and used primarily for the diagnosis of cancer.
The global computed tomography (CT) system market is segmented on the basis of product type, end user and geography. On the basis of product type, the global computed tomography (CT) system market is segmented into high slice type (256 and above), mid slice type (32, 64, 128 slice) and low slice type (4, 8 and 16 slice). The segment “mid slice type” is very popular in developed regions of the world that can afford these expensive systems. North America, Japan, Europe and some other countries hold the largest market for mid slice CT systems.
Request A Sample Copy Of This Report at:
http://www.radiantinsights.com/research/global-ct-system-2021/request-sample
Research states that, the market share of mid slice systems in terms of revenue to be largest and will continue to lead the market since they provide an optimum price to performance balance to most healthcare facilities. On the basis of end user, the global computed tomography (CT) system market is segmented into diagnostic centers, hospitals, clinics, imaging centers and so on. On the basis of geography, the global computed tomography (CT) system market is segmented into North America, Asia Pacific, Europe, Latin America and Middle East & Africa.
North America is dominated the global market of computed tomography (CT) system in 2015; whereas the Asia Pacific is expected to grow during the forecast period. The key players of global computed tomography (CT) system market are Beckman, SEKISUI MEDICAL, Roche Diagnostics, Randox Laboratories, Reigncom, Zhejiang Erkn, Zybio, Hitachi Ltd., Siemens AG, Toshiba Medical Systems, Koninklijke Philips N.V., GE Healthcare, Philips Healthcare, and Trivitron Technologies.
Explore Other Reports By Radiant Insights,Inc at:
Acute Heart Failure Global Clinical Trials Review-
http://www.radiantinsights.com/research/acute-heart-failure-global-clinical-trials-review-h1-2017
Acute Ischemic Stroke Global Clinical Trials Review-
http://www.radiantinsights.com/research/acute-ischemic-stroke-global-clinical-trials-review-h1-2017
Acute Lung Injury Global Clinical Trials Review-
http://www.radiantinsights.com/research/acute-lung-injury-global-clinical-trials-review-h1-2017
About Radiant Insights,Inc
Radiant Insights is a platform for companies looking to meet their market research and business intelligence requirements. We assist and facilitate organizations and individuals procure market research reports, helping them in the decision making process. We have a comprehensive collection of reports, covering over 40 key industries and a host of micro markets. In addition to over extensive database of reports, our experienced research coordinators also offer a host of ancillary services such as, research partnerships/ tie-ups and customized research solutions.
Media Contact
Company Name: Radiant Insights, Inc.
Contact Person: Michelle Thoras, Corporate Sales Specialist – USA
Email: sales@radiantinsights.com
Phone: (415) 349-0054, Toll Free: 1-888-202-9519
Address:28 2nd Street, Suite 3036
City: San Francisco
State: California
Country: United States
Website: http://www.radiantinsights.com/research/global-ct-system-2021